Saba Capital Management’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Saba Capital Management’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-144,956	Closed	-$4.36K	–	492
2023 Q4	$4.36K	Hold	144,956	–	–	﹤0.01%	446
2023 Q3	$8.53K	Hold	144,956	–	–	﹤0.01%	504
2023 Q2	$3.33K	Hold	144,956	–	–	﹤0.01%	595
2023 Q1	$13.8K	Hold	144,956	–	–	﹤0.01%	672
2022 Q4	$9.49K	Hold	144,956	–	–	﹤0.01%	808
2022 Q3	$11K	Hold	144,956	–	–	﹤0.01%	1010
2022 Q2	$30K	Hold	144,956	–	–	﹤0.01%	961
2022 Q1	$60K	Hold	144,956	–	–	﹤0.01%	854
2021 Q4	$65K	Buy	+144,956	New	+$68.5K	﹤0.01%	718

Other funds holding PEPLW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Saba Capital Management's PEPLW Position: Q1 2024 in Review

Saba Capital Management sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2024, closing a stake of 144,956 shares — an estimated $4.36K sold.

Saba Capital Management first reported a position in PEPLW in Q4 2021 and held it in 9 quarters. The position peaked at $65K in Q4 2021. 1 fund tracked by Wall St. Rank holds PEPLW as of Q1 2024.

Saba Capital Management reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2024 after selling out during the quarter.
Saba Capital Management sold 144,956 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2024, an estimated $4.36K.
Saba Capital Management first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 9 quarters.
Saba Capital Management's PepperLime Health Acquisition Corporation Warrrant position peaked at $65K in Q4 2021.
1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2024.

Based on Saba Capital Management's 13F filing for Q1 2024, filed 15 May 2024.